Podilfen

This classification denotes a vasodilating agent with the molecular formula C18H23N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LI81FMI713, chemically known as 1-(alpha-methyl-3,4-(methylenedioxy)phenethyl)-4-(4-methyl-2-thiazolyl)piperazine. but generally known as podilfen, which bears US NIH Compound Identifier 3050403. European Medicines Agency schedules Podilfen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09962MIG. The term PODILFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). PODILFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule podilfen under HS 29341000 and SITC 51579. As of Q4 2014, PODILFEN remains the US FDA Preferred Term for this commodity. Podilfen bears US NLM identifiers UMLS ID C1882411 and NCI Concept Code C66448. SMILES: s1c(N2CCN(C(Cc3cc4OCOc4cc3)C)CC2)nc(c1)C.